September 8, 2009 (FinancialWire) — NeuroMetrix, Inc. (NASDAQ: NURO) (Current Market Cap: $32.83 Mil.) has appointed Thomas T. Higgins as senior vice president and chief financial officer.

Higgins formerly served as EVP and CFO at Caliper Life Sciences, a provider of technology and services for life sciences research. Before Caliper, he was EVP of operations and CFO at V.I. Technologies, a biotechnology company addressing blood safety. Before that he served at Cabot from 1985 in various senior finance and operations roles.

Waltham, Massachusetts-based NeuroMetrix offers products for preservation and restoration of nerve and spinal cord function, and pain control. The company’s focus has been primarily on the assessment of neuropathies.

Neuropathies affect the peripheral nerves and parts of the spine and are frequently caused by or associated with carpal tunnel syndrome, diabetes, sciatica, and other clinical disorders. The company markets systems for the performance of nerve conduction studies and needle electromyography procedures.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.